SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001408870-15-000004
Filing Date
2015-05-04
Accepted
2015-05-04 16:11:05
Documents
1
Period of Report
2015-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_143077025559176.html 4  
1 FORM 4 wf-form4_143077025559176.xml 4 3856
  Complete submission text file 0001408870-15-000004.txt   5339
Mailing Address 3200 BEECHLEAF COURT SUITE 900 RALEIGH NC 27604
Business Address 3200 BEECHLEAF COURT SUITE 900 RALEIGH NC 27604 (609) 986-1780
NephroGenex, Inc. (Issuer) CIK: 0001338095 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O FOREST LABORATORIES, INC. 909 THIRD AVENUE NEW YORK NY 10022
Business Address
Taglietti Marco (Reporting) CIK: 0001408870 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36303 | Film No.: 15828543